Acadian Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.86M | Buy |
|
|||||
|
2025
Q2 | $4.91M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.14M | Sell |
|
|||||
|
2024
Q1 | $9.71M | Sell |
|
|||||
|
2023
Q4 | $8.57M | Sell |
|
|||||
|
2023
Q3 | $8.23M | Sell |
|
|||||
|
2023
Q2 | $6.82M | Sell |
|
|||||
|
2023
Q1 | $4.19M | Hold |
|
|||||
|
2022
Q4 | $4.32M | Hold |
|
|||||
|
2022
Q3 | $2.37M | Buy |
|
|||||
|
2022
Q2 | $2.59M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $40K | Buy |
|
|||||
|
2021
Q1 | $7K | Sell |
|
|||||
|
2020
Q4 | $2.34M | Buy |
|
|||||
|
2020
Q3 | $1.8M | Buy |
|
|||||
|
2020
Q2 | $50K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $649K | Sell |
|
|||||
|
2018
Q2 | $1M | Sell |
|
|||||
|
2018
Q1 | $2.86M | Sell |
|
|||||
|
2017
Q4 | $9.3M | Sell |
|
|||||
|
2017
Q3 | $14.3M | Buy |
|
|||||
|
2017
Q2 | $5.33M | Buy |
|
|||||
|
2017
Q1 | $2.73M | Buy |
|